Clinical Trials Directory

Trials / Conditions / Malignant Ovarian Brenner Tumor

Malignant Ovarian Brenner Tumor

7 registered clinical trials studyying Malignant Ovarian Brenner Tumor.

StatusTrialSponsorPhase
TerminatedThe Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors
NCT03641287
University of WashingtonN/A
TerminatedPaclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, F
NCT02923739
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingMV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Can
NCT02068794
Mayo ClinicPhase 1 / Phase 2
UnknownDiet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previo
NCT00719303
Gynecologic Oncology GroupPhase 3
CompletedFirst-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ov
NCT01097746
M.D. Anderson Cancer CenterPhase 2
CompletedBevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epi
NCT00951496
National Cancer Institute (NCI)Phase 3
TerminatedYKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal
NCT00899093
Gynecologic Oncology Group